Ripasudil 0.4% Eye Drops in Fuchs Endothelial Corneal Dystrophy

Clinical trial NCT03575130 · UNKNOWN

Trial details

NCT number: NCT03575130
Sponsor: University of Erlangen-Nürnberg Medical School
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Fuchs' Endothelial Dystrophy Fuchs Dystrophy Corneal Endothelial Dystrophy Corneal Endothelial Cell Loss Cornea Guttata

Start date: 2018-06-05
Primary completion: 2018-12-31
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.